Eshelman Innovation Curation Program (Therapeutics Accelerator)
Offers translational awards at the University of North Carolina for therapeutic innovations in cancer, brain, and infection treatment.
About
Eshelman Innovation's Therapeutics Accelerator funds novel therapeutics in oncology, neuroscience, and infectious disease from discovery through preclinical and early development. The Innovation Curation Program is the core funding mechanism: a 5-stage process (Opportunity Mapping → Stakeholder Engagement → Event Summit → Joint RFP → Co-Creation/Investment) that partners UNC researchers with bioph…
Max award—
Realistic median—
Success rate—
Decision time—
No upcoming rounds verified. Cadence: Rolling.